The students can check and download Orissa Plus Two merit list PDF on the websites - chseodisha.nic.in, orissaresults.nic.in.
The students can check and download Orissa Plus Two scorecard PDF on the websites - chseodisha.nic.in, orissaresults.nic.in.
The students can download CHSE Odisha 12th scorecard PDF on the websites - chseodisha.nic.in, orissaresults.nic.in. The CHSE Odisha 12th scorecard PDF login credentials are - application number, date ...
The students should know they need to secure a minimum of 33 per cent marks and 30 per cent marks in each subject to clear ...
The TN, Tamil Nadu SSLC, Class 10 result 2026 will be available at indiaresults.com, Digilocker and App, apart from the ...
The students can check and download CHSE Odisha Plus Two scorecard PDF via Digilocker apart from the websites - chseodisha.nic.in, orissaresults.nic.in.
CBSE earlier extended the date for obtaining scanned copies of Class 12 answer sheets, the last date to apply for scanned copies of answer books is May 23, which was set to May 22 earlier. Students ...
Stocktwits on MSN
Why did PBT stock hit a record high today?
The proposed deal would also include US Land Guild, a Blackbeard subsidiary that is expected to hold around 66,500 acres of land. ・Blackbeard and its affiliates could receive certain working interests ...
Stocktwits on MSN
IBRX stock’s decline makes retail see ‘incredible’ buying opportunity after Anktiva + BCG therapy delivered favorable results
The data was presented at the 2026 American Urological Association Annual Meeting. ・Anktiva plus BCG showed a longer median duration of complete response of 22.1 months, compared with 9.7 months with ...
Stocktwits on MSN
Is ZETA stock mispriced? This analyst sees ‘durable advantages’ in ‘high-growth, cash-generating’ platform
The brokerage said investors have “miscast - and mispriced” Zeta as a cyclical digital advertising company. ・BofA highlighted Zeta’s ability to consistently capture share of digital marketing and ...
Stocktwits on MSN
RLAY stock lights up on vascular anomalies treatment data boost – 60% of patients show sharp reduction in lesion volume
The data highlighted the drug’s potential to deliver strong efficacy while maintaining a manageable safety profile suitable for long-term use. ・The study enrolled 32 patients with no adverse events ...
Stocktwits on MSN
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week
The 58-patient studies were conducted at hospitals in Canada and Israel. ・Alpha Tau posted a net loss of $0.26 per share for the first quarter, compared to Wall Street’s estimates of a loss of $0.12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results